Effective optimal control of a wind turbine system with hybrid energy storage and hybrid MPPT approach.

This research paper discusses a wind turbine system and its integration in remote locations using a hybrid power optimization approach and a hybrid storage system. Wind turbine systems' optimization controllers operate MPPT strategies efficiently, optimizing the system's overall performance. The proposed approach is HTb(P&O/FLC), which combines the P&O and FLC methods.

Coordinated power management strategy for reliable hybridization of multi-source systems using hybrid MPPT algorithms.

This research discusses the solar and wind sourcesintegration in aremote location using hybrid power optimization approaches and a multi energy storage system with batteries and supercapacitors. The controllers in PV and wind turbine systems are used to efficiently operate maximum power point tracking (MPPT) algorithms, optimizing the overall system performance while minimizing stress on energy storage components. More specifically, on PV generator, the provided method integrating the Perturb & Observe (P&O) and Fuzzy Logic Control (FLC) methods.

Optimization and intelligent power management control for an autonomous hybrid wind turbine photovoltaic diesel generator with batteries.

In this paper, a critical issue related to power management control in autonomous hybrid systems is presented. Specifically, challenges in optimizing the performance of energy sources and backup systems are proposed, especially under conditions of heavy loads or low renewable energy output. The problem lies in the need for an efficient control mechanism that can enhance power availability while protecting and extending the lifespan of the various power sources in the system.

COMparison of Platelet reactivity following prAsugrel and ticagrelor loading dose in ST-Segment elevation myocardial infarctION patients: The COMPASSION study.

Prasugrel and ticagrelor are potent P2Y12-ADP receptor antagonists which are superior to clopidogrel in acute coronary syndromes. To date no clinical trial directly compared these two drugs. Platelet reactivity correlates with ischemic and bleeding events in patients undergoing percutaneous coronary intervention.